Goodness Growth Holdings Announces Third Quarter 2023 Results

In this article:
Goodness Growth Holdings, Inc.Goodness Growth Holdings, Inc.
Goodness Growth Holdings, Inc.

– Q3 revenue of $24.7 million increased 44.0% YoY and 28.2% sequentially excluding discontinued operations –

– Stronger revenue growth and margins largely driven by adult-use activation in Maryland –

– Record operating income reflects Maryland’s performance and early returns on our strategic plan, despite continued headwinds in New York –

– New York divestiture process taking longer than anticipated –

MINNEAPOLIS, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today reported financial results for its third quarter ended September 30, 2023. Key financial results are presented below in summary form with supporting commentary and discussion from management of certain key operating metrics which the Company uses to judge its performance. All currency figures referenced herein are denominated in U.S. dollars.

 

 

 

 

 

 

 

 

 

 

 

 

Summary of Key Financial Metrics

Three Months Ended

 

Nine Months Ended

US $ in millions

September 30,

 

September 30,

 

2023

 

2022

 

Variance

 

2023

 

2022

 

Variance

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Revenue

$24.7

 

$18.9

 

30.9%

 

$64.0

 

$55.6

 

15.1%

Revenue (excluding discontinued operations)

$24.7

 

$17.1

 

44.0%

 

$62.0

 

$48.2

 

28.4%

GAAP Gross Profit

$13.2

 

$9.5

 

38.4%

 

$32.0

 

$22.4

 

43.1%

Gross Profit Margin

53.5%

 

50.6%

 

290 bps

 

50.1%

 

40.3%

 

980 bps

SG&A Expenses

$6.7

 

$8.5

 

-20.5%

 

$22.0

 

$26.4

 

-16.8%

SG&A Expenses (% of Sales)

27.4%

 

45.0%

 

1,760 bps

 

34.3%

 

47.5%

 

1,320 bps

Operating Income (Loss)

$5.9

 

($0.2)

 

NM

 

$5.2

 

($7.6)

 

NM

Operating Income Margin

23.8%

 

(1.0%)

 

2,480 bps

 

8.1%

 

-13.7%

 

2,180 bps

EBITDA

$7.0

 

($1.2)

 

NM

 

$11.3

 

($10.8)

 

NM

EBITDA Margin

28.5%

 

(6.5%)

 

3,500 bps

 

17.7%

 

(19.4%)

 

3,710 bps

NM = Not Meaningful

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Management Commentary

Interim Chief Executive Officer Josh Rosen commented, “The strength of our third quarter results reflects a combination of benefits from our recent operational improvement initiatives and regulatory catalysts in Maryland following the launch of adult use sales in July. We are very proud of our team, who have adapted quickly to our decentralized approach to operations. These efforts and the substantial regulatory catalyst in Maryland enabled us to produce positive cash flow from operations in the quarter. De-risking our balance sheet remains a critical focus, and while we have not yet executed definitive documents related to our divestiture process in New York, we expect to do so before the end of this year and look forward to sharing more visibility into our future profitability expectations once that process is complete.”

Amber Shimpa, President and CEO of Vireo Health of Minnesota commented, “Our operational key performance indicators continued to improve during the quarter despite the seasonal challenges we experience in our greenhouse environment in Minnesota. We are encouraged by the strength of our performance in the Maryland market following the implementation of adult-use. Based on early indications, we believe we are outpacing the overall market growth in Maryland, which is an internal goal and standard by which we measure our performance. In Minnesota, we remain focused on driving better value and quality of products for patients as we move out of what is seasonally a very challenging climate for our flower production.”

 

 

 

 

 

 

 

 

 

 

 

 

Core Market KPIs1

Three Months Ended

 

Nine Months Ended

US $ in millions

September 30,

 

September 30,

 

2023

 

2022

 

Variance

 

2023

 

2022

 

Variance

Total Harvest Pounds (Biomass)

9,111

 

7,530

 

21.0%

 

27,142

 

20,727

 

30.9%

% "A" Flower2

20.5%

 

18.7%

 

180 bps

 

19.5%

 

16.9%

 

260 bps

Total Retail Revenue

$20.1

 

$14.7

 

37.4%

 

$51.8

 

$40.9

 

26.8%

Same Store Sales Growth

-

 

-

 

37.4%

 

-

 

-

 

26.8%

Minnesota

-

 

-

 

15.0%

 

-

 

-

 

26.6%

New York

-

 

-

 

-14.0%

 

-

 

-

 

-16.7%

Maryland

-

 

-

 

229.4%

 

-

 

-

 

88.7%

Total Wholesale Revenue

$4.5

 

$2.5

 

83.7%

 

$9.9

 

$7.4

 

34.5%

1Core Markets refer to the Company's operations in Maryland, Minnesota, and New York.

2"A Flower" refers to produced biomass that meet the Company's highest internal standards for flower quality, size, and appearance.

 

Other Events

On August 14, 2023, the Company announced that it has entered into consulting, licensing and wholesale agreements with two additional dispensaries in Maryland that are owned and controlled by HA-MD LLC and currently operate under the Ethos brand name. The agreements will result in the two Ethos dispensaries in Hampden and Rockville being, upon regulatory approval, rebranded to Green Goods® and include an option to acquire the two dispensaries if and when allowed by applicable law and regulations.

On October 5, 2023, the Company announced that it completed previously disclosed warrant issuances with Grown Rogue International, Inc. Goodness Growth issued 10,000,000 warrants to purchase subordinate voting shares of Goodness Growth to Grown Rogue, with a strike price equal to C$0.317 (US$0.233), which represented a 25.0 percent premium to the 10-day volume weighted average price (“VWAP”) of Goodness Growth’s subordinate voting shares on the trading day immediately prior to the effective date of the Agreement. Similarly, Grown Rogue issued 8,500,000 warrants to purchase shares of Grown Rogue to Goodness Growth, with a strike price equal to C$0.225 (US$0.166), which represented a 25.0 percent premium to the 10-day VWAP of Grown Rogue’s subordinate voting shares on the trading day immediately prior to the effective date of the Agreement. The warrants exchanged in the agreement were issued with five-year terms to exercise.

On October 30, 2023, the Company announced that it executed a fifth amendment to its lease with its landlord on its cannabis cultivation and manufacturing facilities located in Johnstown, New York. The Company and its landlord agreed to increase the tenant improvement allowance on the lease by an additional $14.0 million, with the increase in funds to be utilized to support the completion of the construction of the Company’s indoor expansion project which was announced in September 2021. The parties also agreed to a monthly base rental increase of $210,000 beginning November 2023. Goodness Growth management stated that the amendment is intended to support the Company’s ongoing divestment process in the State of New York.

Balance Sheet and Liquidity

As of September 30, 2023, total current assets were $135.1 million, including cash on hand of $13.3 million. Total current liabilities were $165.4 million.

As of September 30, 2023, including the required issuance of warrants to Grown Rogue International, Inc., the Company had a total of 143,126,330 equity shares issued and outstanding on an as-converted basis, 236,986,611 shares outstanding on an as-converted, fully diluted basis, and 153,573,359 fully-diluted shares outstanding on the treasury method basis.

Conference Call and Webcast Information

Goodness Growth management will host a conference call with research analysts today, November 14, 2023, at 5:00 p.m. ET (4:00 p.m. CT) to discuss its financial results for its third quarter ended September 30, 2023. Interested parties may attend the conference call by dialing 1-888-414-4585 (Toll-Free) (US and Canada) or 1-646-960-0331 (Toll) (International) and referencing conference ID number 8663261.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link:
https://events.q4inc.com/attendee/917057239.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc. is a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. Today, the Company is licensed to grow, process, and/or distribute cannabis in four markets and operates 14 dispensaries in three states. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com.

Additional Information

Additional information relating to the Company’s third quarter 2023 results will be available on EDGAR and SEDAR later today. Goodness Growth refers to certain non-GAAP financial measures such as Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) in circumstances in which the Company believes that doing so provides additional perspective and insights when analyzing the core operating performance of the business. These measures do not have any standardized meaning and may not be comparable to similar measures presented by other issuers. Please see the Supplemental Information and Reconciliation of Non-GAAP Financial Measures at the end of this news release for more detailed information regarding non-GAAP financial measures.

Contact Information

Investor Inquiries:
Sam Gibbons
Managing Director
sam.gibbons@alpha-ir.com
(612) 314-8995

Media Inquiries:
Amanda Hutcheson
Senior Manager, Communications
amandahutcheson@goodnessgrowth.com   
(919) 815-1476

 

 

Forward-Looking Statement Disclosure

This press release contains “forward-looking information” within the meaning of applicable United States and Canadian securities legislation. To the extent any forward-looking information in this press release constitutes “financial outlooks” within the meaning of applicable United States or Canadian securities laws, this information is being provided as preliminary financial results; the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information contained in this press release may be identified by the use of words such as “should,” “believe,” “estimate,” “would,” “looking forward,” “may,” “continue,” “expect,” “expected,” “will,” “likely,” “intend,” “subject to,” “transformation,” and “pending,” variations of such words and phrases, or any statements or clauses containing verbs in any future tense. These statements should not be read as guarantees of future performance or results. Forward-looking information includes both known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company or its subsidiaries to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information contained in this press release. Financial outlooks, as with forward-looking information generally, are, without limitation, based on the assumptions and subject to various risks as set out herein and in our Annual Report on Form 10-K filed with the Securities Exchange Commission. Our actual financial position and results of operations may differ materially from management’s current expectations and, as a result, our revenue, EBITDA, and cash on hand may differ materially from the values provided in this press release. Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management’s experience and perception of trends, current conditions, and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, the reader should not place undue reliance on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to: risks related to the timing and content of adult-use legislation in markets where the Company currently operates; current and future market conditions, including the market price of the subordinate voting shares of the Company; risks related to epidemics and pandemics; federal, state, local, and foreign government laws, rules, and regulations, including federal and state laws and regulations in the United States relating to cannabis operations in the United States and any changes to such laws or regulations; operational, regulatory and other risks; execution of business strategy; management of growth; difficulties inherent in forecasting future events; conflicts of interest; risks inherent in an agricultural business; risks inherent in a manufacturing business; liquidity and the ability of the Company to raise additional financing to continue as a going concern; the Company’s ability to meet the demand for flower in Minnesota; risk of failure in the lawsuit with Verano and the cost of that litigation; our ability to dispose of our assets held for sale at an acceptable price or at all; and risk factors set out in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, which is available on EDGAR with the U.S. Securities and Exchange Commission and filed with the Canadian securities regulators and available under the Company's profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. Except as required by law, we undertake no obligation to update any forward-looking statements or forward-looking information to reflect events or circumstances after the date of such statements.

Supplemental Information

The financial information reported in this news release is based on unaudited financial statements for the fiscal quarters ended September 30, 2023, and September 30, 2022. All financial information contained in this news release is qualified in its entirety with reference to such financial statements. To the extent that the financial information contained in this news release is inconsistent with the information contained in the Company’s audited financial statements, the financial information contained in this news release shall be deemed to be modified or superseded by the Company’s audited financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws.

 

 

 

 

 

 

 

GOODNESS GROWTH HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS AS OF 9/30/2023 AND 12/31/2022

(Amounts Expressed in United States Dollars, Unaudited and Condensed)

 

 

September 30,

 

December 31,

 

 

2023

 

2022

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash

 

$

13,296,137

 

 

$

15,149,333

 

Accounts receivable, net of allowance for doubtful accounts of $344,937 and $453,860, respectively

 

 

5,688,782

 

 

 

4,286,072

 

Inventory

 

 

19,056,338

 

 

 

20,508,023

 

Prepayments and other current assets

 

 

1,834,013

 

 

 

2,544,532

 

Notes receivable, current

 

 

3,750,000

 

 

 

 

Warrants Receivable

 

 

1,566,445

 

 

 

 

Assets Held for Sale

 

 

89,918,392

 

 

 

4,240,781

 

Total current assets

 

 

135,110,107

 

 

 

46,728,741

 

Property and equipment, net

 

 

23,812,949

 

 

 

89,606,932

 

Operating lease, right-of-use asset

 

 

2,182,174

 

 

 

6,110,787

 

Notes receivable, long-term

 

 

 

 

 

3,750,000

 

Intangible assets, net

 

 

8,935,019

 

 

 

8,776,946

 

Goodwill

 

 

 

 

 

183,836

 

Deposits

 

 

383,645

 

 

 

2,312,161

 

Deferred tax assets

 

 

1,245,000

 

 

 

1,687,000

 

Total assets

 

$

171,668,894

 

 

$

159,156,403

 

Liabilities

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts Payable and Accrued liabilities

 

$

33,638,534

 

 

$

14,928,780

 

Long-Term debt, current portion

 

 

55,432,463

 

 

 

11,780,000

 

Right of use liability

 

 

907,998

 

 

 

1,680,294

 

Liabilities held for sale

 

 

75,439,119

 

 

 

1,319,847

 

Total current liabilities

 

 

165,418,114

 

 

 

29,708,921

 

Right-of-use liability

 

 

9,700,492

 

 

 

79,757,994

 

Other long-term liabilities

 

 

235,577

 

 

 

 

Convertible debt, net

 

 

5,107,477

 

 

 

 

Long-Term debt

 

 

4,060,633

 

 

 

46,248,604

 

Total liabilities

 

$

184,522,293

 

 

$

155,715,519

 

Stockholders’ equity

 

 

 

 

 

 

Subordinate Voting Shares ($- par value, unlimited shares authorized; 108,332,330 shares issued and outstanding)

 

 

 

 

 

 

Multiple Voting Shares ($- par value, unlimited shares authorized; 347,940 shares issued and outstanding)

 

 

 

 

 

 

Super Voting Shares ($- par value; unlimited shares authorized; 0 shares issued and outstanding)

 

 

 

 

 

 

Additional Paid in Capital

 

 

185,991,816

 

 

 

181,321,847

 

Accumulated deficit

 

 

(198,845,215

)

 

 

(177,880,963

)

Total stockholders' equity

 

$

(12,853,399

)

 

$

3,440,884

 

Total liabilities and stockholders' equity

 

$

171,668,894

 

 

$

159,156,403

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

GOODNESS GROWTH HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

(Amounts Expressed in United States Dollars, Unaudited and Condensed)

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2023

 

2022

 

2023

 

2022

Revenue

 

$

24,675,145

 

 

$

18,854,101

 

 

$

63,960,125

 

 

$

55,582,821

 

Cost of sales

 

 

 

 

 

 

 

 

 

 

 

 

Product costs

 

 

10,493,561

 

 

 

9,186,241

 

 

 

30,347,357

 

 

 

29,532,469

 

Inventory valuation adjustments

 

 

984,196

 

 

 

131,000

 

 

 

1,563,872

 

 

 

3,657,788

 

Gross profit

 

 

13,197,388

 

 

 

9,536,860

 

 

 

32,048,896

 

 

 

22,392,564

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

6,749,314

 

 

 

8,489,728

 

 

 

21,965,576

 

 

 

26,393,136

 

Stock-based compensation expenses

 

 

296,617

 

 

 

896,081

 

 

 

4,009,415

 

 

 

2,636,594

 

Depreciation

 

 

99,929

 

 

 

167,940

 

 

 

377,121

 

 

 

487,164

 

Amortization

 

 

180,034

 

 

 

172,267

 

 

 

498,828

 

 

 

516,800

 

Total operating expenses

 

 

7,325,894

 

 

 

9,726,016

 

 

 

26,850,940

 

 

 

30,033,694

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (loss) from operations

 

 

5,871,494

 

 

 

(189,156

)

 

 

5,197,956

 

 

 

(7,641,130

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Impairment of long-lived assets

 

 

 

 

 

(2,108,703

)

 

 

 

 

 

(7,476,618

)

Gain (loss) on disposal of assets

 

 

(50,686

)

 

 

 

 

 

(2,798,567

)

 

 

168,359

 

Gain (loss) on sale of property and equipment

 

 

 

 

 

7,583

 

 

 

 

 

 

(3,347

)

Interest expenses, net

 

 

(7,915,658

)

 

 

(5,573,263

)

 

 

(22,795,242

)

 

 

(15,472,885

)

Other income (expenses)

 

 

345,824

 

 

 

79,750

 

 

 

6,166,472

 

 

 

1,196,975

 

Other income (expenses), net

 

 

(7,620,520

)

 

 

(7,594,633

)

 

 

(19,427,337

)

 

 

(21,587,516

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

(1,749,026

)

 

 

(7,783,789

)

 

 

(14,229,381

)

 

 

(29,228,646

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Current income tax expenses

 

 

(3,980,000

)

 

 

(1,790,000

)

 

 

(7,357,871

)

 

 

(4,130,000

)

Deferred income tax recoveries

 

 

500,000

 

 

 

1,150,000

 

 

 

623,000

 

 

 

4,185,000

 

Net loss and comprehensive loss

 

 

(5,229,026

)

 

 

(8,423,789

)

 

 

(20,964,252

)

 

 

(29,173,646

)

Net loss per share - basic and diluted

 

$

(0.04

)

 

$

(0.07

)

 

$

(0.16

)

 

$

(0.23

)

Weighted average shares used in computation of net loss per share - basic & diluted

 

 

141,332,852

 

 

 

128,120,949

 

 

 

132,576,879

 

 

 

128,114,570

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

GOODNESS GROWTH HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

(Amounts Expressed in United States Dollars, Unaudited and Condensed)

 

 

September 30,

 

 

2023

 

2022

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

$

(20,964,252

)

 

$

(29,173,646

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

Inventory valuation adjustments

 

 

1,563,872

 

 

 

3,657,788

 

Depreciation

 

 

377,121

 

 

 

487,164

 

Depreciation capitalized into inventory

 

 

1,846,418

 

 

 

1,959,536

 

Non-cash operating lease expense

 

 

423,821

 

 

 

852,687

 

Amortization of intangible assets

 

 

498,828

 

 

 

516,800

 

Amortization of intangible assets capitalized into inventory

 

 

24,779

 

 

 

 

Stock-based payments

 

 

4,009,415

 

 

 

2,636,594

 

Warrants receivable

 

 

(1,566,445

)

 

 

 

Interest Expense

 

 

5,111,930

 

 

 

3,430,733

 

Impairment of long-lived assets

 

 

 

 

 

7,476,618

 

Deferred income tax

 

 

(623,000

)

 

 

(4,185,000

)

Accretion

 

 

800,392

 

 

 

3,407,030

 

Loss (gain) on sale of property and equipment

 

 

 

 

 

3,347

 

Loss on disposal of Red Barn Growers

 

 

2,909,757

 

 

 

 

Loss (gain) on disposal of assets

 

 

(111,190

)

 

 

 

Gain on disposal of royalty asset

 

 

 

 

 

(168,359

)

Change in operating assets and liabilities:

 

 

 

 

 

Accounts Receivable

 

 

(902,709

)

 

 

(1,408,580

)

Prepaid expenses

 

 

684,987

 

 

 

(1,601,742

)

Inventory

 

 

(1,932,554

)

 

 

(2,205,236

)

Accounts payable and accrued liabilities

 

 

7,459,350

 

 

 

2,360,044

 

Change in assets and liabilities held for sale

 

 

(116,882

)

 

 

 

Net cash used in operating activities

 

$

(506,362

)

 

$

(11,954,222

)

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

PP&E Additions

 

$

(2,630,724

)

 

$

(4,938,587

)

Intangible license additions

 

 

(1,090,919

)

 

 

 

Proceeds from sale of Red Barn Growers net of cash

 

 

439,186

 

 

 

387,512

 

Proceeds from sale of property, plant, and equipment

 

 

242,088

 

 

 

 

Proceeds from sale of royalty asset

 

 

 

 

 

236,635

 

Deposits

 

 

(263,545

)

 

 

(482,539

)

Net cash provided by (used in) investing activities

 

$

(3,303,914

)

 

$

(4,796,979

)

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

$

 

 

$

 

Proceeds from long-term debt, net of issuance costs

 

 

 

 

 

24,868,143

 

Proceeds from convertible debt, net of issuance costs

 

 

5,348,140

 

 

 

 

Proceeds from option exercises

 

 

 

 

 

7,201

 

Debt principal payments

 

 

(1,976,362

)

 

 

 

Lease principal payments

 

 

(1,414,698

)

 

 

(1,437,346

)

Net cash provided by (used in) financing activities

 

$

1,957,080

 

 

$

23,437,998

 

 

 

 

 

 

 

 

Net change in cash

 

$

(1,853,196

)

 

$

6,686,797

 

Cash, beginning of period

 

$

15,149,333

 

 

$

15,155,279

 

Cash, end of period

 

$

13,296,137

 

 

$

21,842,076

 

 

 

 

 

 

 

 


 

GOODNESS GROWTH HOLDINGS, INC.
STATE-BY-STATE REVENUE PERFORMANCE
THREE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

September 30,

 

 

 

 

 

 

 

 

2023

 

2022

 

$ Change

 

% Change

 

Retail:

 

 

 

 

 

 

 

 

 

 

 

 

MN

 

$

11,791,001

 

 

$

10,252,523

 

 

$

1,538,478

 

 

15

 

%

NY

 

 

2,185,701

 

 

 

2,541,913

 

 

 

(356,212

)

 

(14

)

%

NM

 

 

 

 

 

1,721,017

 

 

 

(1,721,017

)

 

(100

)

%

MD

 

 

6,170,372

 

 

 

1,873,773

 

 

 

4,296,599

 

 

229

 

%

Total Retail

 

$

20,147,074

 

 

$

16,389,226

 

 

$

3,757,848

 

 

23

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Wholesale:

 

 

 

 

 

 

 

 

 

 

 

 

MD

 

 

2,923,376

 

 

 

1,333,864

 

 

 

1,589,512

 

 

119

 

%

NY

 

 

1,375,730

 

 

 

1,131,011

 

 

 

244,719

 

 

22

 

%

NM

 

 

 

 

 

 

 

 

 

 

100

 

%

Total Wholesale

 

$

4,299,106

 

 

$

2,464,875

 

 

$

1,834,231

 

 

74

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

MD Service Revenue

 

 

228,965

 

 

 

 

 

 

228,965

 

 

100

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Revenue

 

$

24,675,145

 

 

$

18,854,101

 

 

$

5,821,044

 

 

31

 

%

AZ and NM Revenue

 

$

 

 

$

(1,721,017

)

 

$

1,721,017

 

 

(100

)

%

Total Revenue excluding AZ and NM

 

$

24,675,145

 

 

$

17,133,084

 

 

$

7,542,061

 

 

44

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 


 

GOODNESS GROWTH HOLDINGS, INC.
STATE-BY-STATE REVENUE PERFORMANCE
NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

 

 

 

 

 

 

September 30,

 

 

 

 

 

 

 

 

2023

 

2022

 

$ Change

 

% Change

 

Retail:

 

 

 

 

 

 

 

 

 

 

 

 

MN

 

$

33,989,289

 

 

$

26,844,812

 

 

$

7,144,477

 

 

27

 

%

NY

 

 

6,827,278

 

 

 

8,193,540

 

 

 

(1,366,262

)

 

(17

)

%

NM

 

 

1,964,285

 

 

 

4,984,945

 

 

 

(3,020,660

)

 

(61

)

%

MD

 

 

10,981,121

 

 

 

5,819,644

 

 

 

5,161,477

 

 

89

 

%

Total Retail

 

$

53,761,973

 

 

$

45,842,941

 

 

$

7,919,032

 

 

17

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Wholesale:

 

 

 

 

 

 

 

 

 

 

 

 

AZ

 

$

 

 

$

2,355,683

 

 

$

(2,355,683

)

 

(100

)

%

MD

 

 

6,324,396

 

 

 

4,162,287

 

 

 

2,162,109

 

 

52

 

%

NY

 

 

3,605,064

 

 

 

2,549,770

 

 

 

1,055,294

 

 

41

 

%

NM

 

 

39,727

 

 

 

 

 

 

39,727

 

 

100

 

%

MN

 

 

 

 

 

672,140

 

 

 

(672,140

)

 

(100

)

%

Total Wholesale

 

$

9,969,187

 

 

$

9,739,880

 

 

$

229,307

 

 

2

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

MD Service Revenue

 

 

228,965

 

 

 

-

 

 

 

228,965

 

 

100

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Revenue

 

$

63,960,125

 

 

$

55,582,821

 

 

$

8,377,304

 

 

15

 

%

AZ and NM Revenue

 

$

(2,004,012

)

 

$

(7,340,628

)

 

$

5,336,616

 

 

(73

)

%

Total Revenue excluding AZ and NM

 

$

61,956,113

 

 

$

48,242,193

 

 

$

13,713,920

 

 

28

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Non-GAAP Financial Measures

Goodness Growth management occasionally elects to provide certain non-GAAP financial measures such as Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). EBITDA is a non-GAAP measure and does not have a standardized definition under GAAP. The following information provides reconciliations of the supplemental non-GAAP financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented.

 

Reconciliation of Net Loss to EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2023

 

2022

 

2023

 

2022

Net income (loss)

 

$

(5,229,026

)

 

$

(8,423,789

)

 

 

(20,964,252

)

 

 

(29,173,646

)

Interest expense, net

 

 

7,915,658

 

 

 

5,573,263

 

 

 

22,795,242

 

 

 

15,472,885

 

Income taxes

 

 

3,480,000

 

 

 

640,000

 

 

 

6,734,871

 

 

 

(55,000

)

Depreciation & Amortization

 

 

279,963

 

 

 

340,207

 

 

 

875,949

 

 

 

1,003,964

 

Depreciation included in cost of goods sold

 

 

577,132

 

 

 

645,480

 

 

 

1,871,197

 

 

 

1,959,536

 

EBITDA (non-GAAP)

 

$

7,023,727

 

 

$

(1,224,839

)

 

 

11,313,007

 

 

 

(10,792,261

)

 

 

 

 

 

 

 

 

 

 

 

 

 


Advertisement